LABU Holdings Information

LABU is an equity ETF with a total of 167 individual holdings.

Total Holdings

167

Top 10 Percentage

39.95%

Asset Class

Equity

ETF Category

Trading--Leveraged Equity

Assets

529.06M

PE Ratio

n/a

Breakdown by Sector

No.	Symbol	Name	% Weight	Shares
1	n/a	Dreyfus Govt Cash Man Ins	16.85%	91,669,738
2	n/a	Goldman Sachs Fin Gov 465 Institut	4.70%	25,588,640
3	n/a	Goldman Finl Sq Trsry Inst 506	4.34%	23,617,742
4	n/a	S&P Biotechnology Select Industry Index Swap	4.17%	25,717
5	n/a	S&P Biotechnology Select Industry Index Swap	2.46%	40,672
6	n/a	S&P Biotechnology Select Industry Index Swap	2.05%	15,532
7	n/a	S&P Biotechnology Select Industry Index Swap	1.60%	19,286
8	RVMD	Revolution Medicines, Inc.	1.30%	46,669
9	TVTX	Travere Therapeutics, Inc.	1.28%	157,068
10	TGTX	TG Therapeutics, Inc.	1.18%	165,696
11	ALKS	Alkermes plc	1.13%	167,366
12	n/a	S&P Biotechnology Select Industry Index Swap	1.13%	8,962
13	TWST	Twist Bioscience Corporation	1.10%	99,182
14	ARWR	Arrowhead Pharmaceuticals, Inc.	1.10%	79,993
15	NBIX	Neurocrine Biosciences, Inc.	1.03%	35,875
16	CYTK	Cytokinetics, Incorporated	1.03%	73,043
17	EXEL	Exelixis, Inc.	1.03%	111,321
18	MDGL	Madrigal Pharmaceuticals, Inc.	1.02%	10,769
19	CELC	Celcuity Inc.	1.02%	40,151
20	KRYS	Krystal Biotech, Inc.	1.00%	18,225
21	PRAX	Praxis Precision Medicines, Inc.	0.99%	15,648
22	SRRK	Scholar Rock Holding Corporation	0.95%	107,628
23	n/a	S&P Biotechnology Select Industry Index Swap	0.95%	6,011
24	BEAM	Beam Therapeutics Inc.	0.94%	178,212
25	APGE	Apogee Therapeutics, Inc.	0.93%	62,232

Showing 25 of 167 holdings

Subscribe to see the full list

As of May 21, 2026